Here's the live share price of Sanofi India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Sanofi India has declined 9.26% CAGR. Over the past year, the corresponding return has been -29.71%.
Sanofi India’s current P/E of 28.29x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Sanofi India | -0.59 | -0.70 | -17.63 | -9.86 | -29.71 | -5.97 | -9.26 |
Sun Pharmaceutical Industries | 1.72 | -0.19 | -4.84 | -2.78 | -12.83 | 21.97 | 26.07 |
Divi's Laboratories | -1.82 | 0.59 | -10.34 | 8.70 | 10.77 | 17.89 | 13.85 |
Cipla | -1.05 | 3.83 | 2.57 | 7.94 | -4.09 | 13.61 | 16.56 |
Torrent Pharmaceuticals | -0.59 | -1.06 | 11.52 | 16.85 | 4.03 | 33.36 | 20.31 |
Dr. Reddy's Laboratories | 3.93 | 6.85 | -3.54 | 16.65 | -1.48 | 15.18 | 8.16 |
Mankind Pharma | 1.32 | 6.71 | 9.33 | 17.63 | 6.84 | 22.22 | 12.79 |
Zydus Lifesciences | 3.16 | 9.26 | 6.67 | 16.01 | -6.13 | 40.48 | 23.06 |
Lupin | 2.61 | 2.25 | -1.85 | 0.69 | -9.91 | 43.63 | 15.52 |
Abbott India | -4.03 | -6.37 | -2.29 | 1.29 | 4.76 | 19.46 | 12.93 |
Alkem Laboratories | 1.67 | 11.36 | 10.35 | 12.92 | -14.03 | 18.95 | 13.22 |
Aurobindo Pharma | 7.19 | 5.40 | -4.35 | 1.70 | -26.38 | 26.29 | 6.69 |
Glenmark Pharmaceuticals | 6.54 | 3.55 | 29.63 | 51.43 | 22.75 | 75.86 | 34.32 |
Biocon | 1.93 | 6.36 | 2.68 | 10.59 | -5.60 | 6.23 | -3.41 |
GlaxoSmithKline Pharmaceuticals | 0.63 | 6.33 | -15.41 | 7.64 | 0.11 | 26.22 | 11.31 |
Laurus Labs | 2.46 | 7.65 | 32.23 | 55.89 | 76.70 | 17.85 | 28.89 |
Anthem Biosciences | -2.73 | 8.94 | 12.41 | 12.41 | 12.41 | 3.98 | 2.37 |
Cohance Lifesciences | 10.87 | 6.03 | -0.50 | -13.73 | -16.31 | 27.94 | 23.52 |
Ipca Laboratories | -2.11 | -2.04 | -5.71 | 1.51 | -8.73 | 14.40 | 5.38 |
Gland Pharma | 4.15 | 1.51 | 16.89 | 22.12 | 4.01 | -5.96 | 1.55 |
Over the last one year, Sanofi India has declined 29.71% compared to peers like Sun Pharmaceutical Industries (-12.83%), Divi's Laboratories (10.77%), Cipla (-4.09%). From a 5 year perspective, Sanofi India has underperformed peers relative to Sun Pharmaceutical Industries (26.07%) and Divi's Laboratories (13.85%).
Day | SMA | EMA |
---|---|---|
5 | 5,123.99 | 5,085.12 |
10 | 5,156.23 | 5,112.05 |
20 | 5,155.08 | 5,192.23 |
50 | 5,625.64 | 5,454.58 |
100 | 5,881.49 | 5,667.07 |
200 | 5,820.67 | 5,935.56 |
In the latest quarter, Sanofi India saw a drop in promoter holding to 60.39%, while DII stake increased to 23.06%, FII holding rose to 5.61%, and public shareholding moved down to 10.94% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
SBI Magnum Midcap Fund | 3,77,124 | 0.97 | 219.67 |
SBI Contra Fund | 2,51,576 | 0.31 | 146.54 |
Aditya Birla Sun Life Frontline Equity Fund | 2,51,219 | 0.48 | 146.34 |
Nippon India Pharma Fund | 2,30,272 | 1.54 | 134.13 |
Nippon India Growth Fund | 2,26,766 | 0.34 | 132.09 |
Nippon India Small Cap Fund | 2,13,992 | 0.19 | 124.65 |
Nippon India Multi Cap Fund | 1,52,371 | 0.19 | 88.76 |
SBI Long Term Equity Fund | 1,47,988 | 0.28 | 86.2 |
Aditya Birla Sun Life India GenNext Fund | 75,252 | 0.7 | 43.83 |
Aditya Birla Sun Life Midcap Fund | 64,630 | 0.62 | 37.65 |
Date Time | Announcement |
---|---|
Sep 12, 2025, 1:16 AM IST | Sanofi India - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
Aug 14, 2025, 2:55 PM IST | Sanofi India - Announcement under Regulation 30 (LODR)-Change in Management |
Aug 13, 2025, 1:26 AM IST | Sanofi India - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
Aug 02, 2025, 5:21 PM IST | Sanofi India - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Aug 01, 2025, 12:46 AM IST | Sanofi India - Announcement under Regulation 30 (LODR)-Change in Management |
Sanofi India Ltd. is a Public Limited Listed company incorporated on 02/05/1956 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1956PLC009794 and registration number is 009794. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 2013.20 Cr. and Equity Capital is Rs. 23.00 Cr. for the Year ended 31/12/2024.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sanofi India is ₹5,076.00 as on Sep 11, 2025.
The Sanofi India is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Sanofi India is ₹11,690.34 Cr as on Sep 11, 2025.
Today’s highest and lowest price of Sanofi India are ₹5,098.50 and ₹5,070.00.
The 52-week high/low is the highest and lowest price at which Sanofi India stock has traded in the past 52-week or nearly a year. The 52-week high of Sanofi India is ₹7,430.95 and 52-week low of Sanofi India is ₹4,145.90 as on Sep 11, 2025.
The Sanofi India has shown returns of -0.04% over the past day, -0.7% for the past month, -17.63% over 3 months, -29.71% over 1 year, -5.97% across 3 years, and -9.26% over 5 years.
P/E ratio of and PB ratio of Sanofi India are 28.29 and 15.25 on Sep 11, 2025. While the company gives a dividend yield of 2.30 per annum.